Press Releases

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across six additional countries in Europe. Moderna plans to establish a commercial presence in Belgium, Denmark, Norway, the Netherlands, Poland,...

BioNTech SE has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution. At a...

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, announced that it plans to expand its Waigaoqiao Free Trade Zone (FTZ) facility...

National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture...

Velocity Clinical Research, the largest fully integrated clinical site organization, announces three key tech investments to expand its patient community, increase client engagement, and speed up drug development across all its 30 integrated locations. In the past 12 months, Velocity...

The 7thedition of Pharmintech Exhibition is goingto take place in Milan from May 3 to 6, 2022 in conjunction with IPACK-IMA, the most important international trade fair in 2022 for processing and packaging solutions. The two events will combine into...

Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and AstraZeneca Colombia S.A.S. have entered into an exclusive licensing agreement for the commercialization of AstraZeneca's drug Pulmicort Respules®. Under the terms of the...